This is a routine inducement grant for a new hire with no trading signal. Monitor for any future material announcements regarding the company's clinical pipeline (ATR 1072 IND clearance) or financing events.
Price Chart
Executive Summary
Atrium Therapeutics granted inducement stock options and RSUs totaling 11,000 shares and 5,500 shares, respectively, to a single new non-executive employee under its 2026 Inducement Plan. This is a routine compensation event with no material financial impact on the company's operations or stock price.
Key Facts
- Inducement grants awarded to one non-executive employee on August 20, 2026.
- Non-qualified stock options for 11,000 shares at $13.48 exercise price.
- Restricted stock units for 5,500 shares.
- Grants vest over 1-4 years subject to continued service.
- Approved by independent directors under Nasdaq Listing Rule 5635(c)(4).
Financial Impact
Minimal — grants of 16,500 total shares represent less than 0.1% of outstanding shares (based on $235M market cap and $13.48 stock price implying ~17.4M shares outstanding).
Risk Factors
- No material risks identified from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-prn-302856886 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 5d ago | Press Release | $8.00 | awaiting T+5 | — | $8.05 (+0.63%) |
Oct 9, 2026 17d ago | 8-K/A | $8.40 $7.67 | ▼ −8.69% | ▼ −6.72% | $8.05 (−4.17%) |
Oct 8, 2026 18d ago | 8-K | $8.26 $7.82 | ▲ +5.33% | ▲ +5.05% | $8.05 (+2.54%) |
Sep 21, 2026 4w ago | Press Release | $9.22 $8.42 | ▼ −8.68% | ▼ −7.49% | $8.05 (−12.69%) |
Aug 20, 2026 9w ago | Press Release | $13.20 $13.64 | ▲ +3.33% | ▲ +2.86% | $8.05 (−39.02%) |
Aug 13, 2026 10w ago | 8-K | $12.84 $13.20 | ▲ +2.80% | ▲ +4.17% | $8.05 (−37.31%) |
Aug 13, 2026 10w ago | Press Release | $12.84 $13.20 | ▲ +2.80% | ▲ +4.17% | $8.05 (−37.31%) |
Jul 20, 2026 13w ago | Press Release | $12.29 $11.57 | ▼ −5.86% | ▼ −4.63% | $8.05 (−34.50%) |
Jul 14, 2026 14w ago | 8-K | $12.30 $12.17 | ▼ −1.06% | ▼ −0.08% | $8.05 (−34.55%) |
May 14, 2026 23w ago | 8-K | $13.23 $13.09 | ▼ −1.06% | ▼ −2.02% | $8.05 (−39.15%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers